County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States. - Wikidata - wikimedia - TriplyDB

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

http://www.wikidata.org/entity/Q39266916

about

The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care.Prescribing of Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis by HIV Medical Providers in the United States, 2013-2014 Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010 Medical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.HIV Care Initiation Delay among Rural Residents in the Southeastern United States, 1996 to 2012.Scaling up HCV prevention and treatment interventions in rural USA - model projections for tackling an increasing epidemic.Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.Geographic Disparities in Access to Syringe Services Programs Among Young Persons With Hepatitis C Virus Infection in the United States.Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.Considerations for the Development of a Substance-Related Care and Prevention Continuum Model.Correlates of Injection Drug Use Among Rural Appalachian Women.Substance Use in Rural Central Appalachia: Current Status and Treatment Considerations.Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers.Tennessee's In-State Vulnerability Assessment for a 'Rapid Dissemination of HIV or HCV Infection' Event Utilizing Data about the Opioid Epidemic.Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas-United States.Detailed Transmission Network Analysis of a Large Opiate-Driven Outbreak of HIV Infection in the United States.Illicit Drug Use, Illicit Drug Use Disorders, and Drug Overdose Deaths in Metropolitan and Nonmetropolitan Areas - United States.The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.Network-Based Research on Rural Opioid Use: an Overview of Methods and Lessons Learned.Opioids, Hepatitis C Virus Infection, and the Missing Vaccine.HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities.The opioid epidemic and injection drug use: MIPIE and health harms related to the injection of prescription opioids.Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.Notes from the Field: HIV Infection Investigation in a Rural Area - West Virginia, 2017.Human immunodeficiency virus and liver disease: A comprehensive update.Access to Syringe Services Programs - Kentucky, North Carolina, and West Virginia, 2013-2017.Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?HIV-1 Transmission Clustering and Phylodynamics Highlight the Important Role of Young Men Who Have Sex with Men

P2860

Q30268556-1B373126-C102-4DAC-A3C0-D904022D6907 Q31162537-BB07A154-3556-45FC-B741-48C2C3B113D6 Q33629173-77C5FB12-1CDF-4748-9CEE-68E680F731F8 Q33696050-AB03AC48-7D65-48B9-8421-23DC3271D664 Q33853664-874E66BC-4A5D-41E6-8F3B-240C57189F4E Q38400394-09817A94-FBB1-4AA7-B022-C864139984C0 Q38666907-4A970CAD-5E64-45A0-AD30-27A69B2E2AE3 Q38753617-81394993-895B-4833-8EB3-764B6F34E8A6 Q38840669-58D07ABD-CAB6-473B-A583-ADCF5D2155A8 Q40083334-1D8190BA-BAED-4321-B45E-DC38A79B48FE Q40097145-010F1173-160F-4EA5-A7E6-9FE60E79FCB9 Q40144468-F4E930A0-C7B8-4477-8492-6CF8885FC429 Q45070698-D641ACDA-FBD0-4A29-B1B0-57C225900900 Q47300268-97035C98-D319-4A0E-8E6B-494BD5947007 Q47330462-B8B73AA5-E2BF-41DB-8BC4-74A508CB54FB Q47584436-BA182547-FE1A-4D95-8BBB-97A113C930C3 Q47613634-EB015662-5BE8-46A7-A653-85C3566855F7 Q47734540-C9CE5959-58AB-4CF9-962D-34994099A201 Q49824510-B57E30AB-0E58-4B88-960D-80CEA9D0C57B Q49862666-2FEF4B8B-7807-4290-ABD3-6B62510BBBA7 Q52315227-876354C9-D213-49A8-A614-833C039B0731 Q52595592-C2DDBA4B-DA63-4BA9-8F0B-6557DF85F4D1 Q52601050-95254FD2-E242-4FBA-A792-E5C31BE28727 Q52622035-C0823EB9-1830-4DB1-89EC-F3E8DAC97648 Q54264145-7A761F82-B5AB-4FE1-975F-BAA329ADEC4F Q55109199-5AD46CA6-171E-48E7-AFC4-238A025640DD Q55249891-03BA6213-7C7C-4627-8F46-6F0FBB03369F Q55425578-40A8E74C-5879-4995-B5C6-52F63670C446 Q56884713-52F87A4A-66BE-455A-8C8D-2024E7D6B6C1

P2860

County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.

http://www.wikidata.org/entity/Q39266916

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@en

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@nl

type

label

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@en

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@nl

prefLabel

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@en

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@nl

P1433

Q39266916-0757BD2F-CEAA-41C1-8D67-CFBF4514479E

P1476

Q39266916-EFC2756B-0627-40B6-B8E8-DA04C4878C33

P2093

Q39266916-0E86D966-383A-4AFE-893A-EDDCF4B91EA7

Q39266916-0EC064C7-7306-49D2-BF48-7ED7E865B805

Q39266916-25DBB84D-F71C-4FAE-97F0-F4D67845F686

Q39266916-4FE82AF7-FAE1-459A-BCE3-E488A63360C2

Q39266916-5CFA0FF6-1D22-4A14-8CF6-884B3EDB461E

Q39266916-6C0FC9F6-7FDC-43DD-92C7-8D33F8AE2164

Q39266916-7EFDC20D-2171-4160-B7C3-C5E271A25342

Q39266916-8EE1361F-1B70-42E3-9D5B-79716F599AC2

Q39266916-9FD2B0A2-B776-4283-A6B5-F41A7C0C4975

Q39266916-A5455570-C773-4AEC-B688-C0C7207E6662

P2860

Q39266916-20EF8206-E2B0-4328-8E19-A2ACC18C26A7

Q39266916-29657549-3F97-40AA-9FDE-C11E3CAE88A3

Q39266916-2C4C760F-FF08-44E1-BA58-540D54A3F9B8

Q39266916-2D492011-E492-4B93-8878-7D95F2B5F0AD

Q39266916-4E986C47-26DB-4BFB-B1BC-250B3C8EF624

Q39266916-85B0EBBD-ED16-4FFA-A4F5-47FDB3C4F2B2

Q39266916-92C0F8DF-29F0-4254-8BA5-72F4124000A1

Q39266916-AFA44A39-3B92-4328-B002-7B7294373852

Q39266916-B71CCEC8-8EEF-48C4-8E4B-C1169F577DC5

Q39266916-BE0711E2-969D-4A13-A424-A14F95EB5C20

P304

Q39266916-42F034A3-FC2F-404E-A305-3082C67E0A6B

P31

Q39266916-9298BF4A-A64B-43B2-B0F9-FB70AAFF547C

P356

Q39266916-512D86B2-812B-4F6C-8494-F7E640C1C7D6

P407

Q39266916-61F2A24F-BC7F-485D-8655-C4A3CF115805

P433

Q39266916-2A91C06D-014A-4AB6-AC52-0DD119FF0E87

P478

Q39266916-DCB74C15-D568-446D-B2C0-43441ADB49A2

P577

Q39266916-8984C827-39AF-4CA5-BB74-D1BE5395CCBE

P698

Q39266916-EDE16FCB-154F-44A6-BB9F-EC7AB81A0195

P921

Q39266916-3D44D1D4-01F1-4B86-A35B-75C5F607B8D9

Q39266916-4206568E-7101-4159-85ED-A8F0271E16B1

P932

Q39266916-54876EA4-3994-4973-BB49-EE33AE76216C

P356

QAI.0000000000001098

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

County-Level Vulnerability Ass ...... o Inject Drugs, United States.

@en

P2093

Andrew L Dent

http://www.w3.org/2001/XMLSchema#string

Azfar-E-Alam Siddiqi

http://www.w3.org/2001/XMLSchema#string

Barry E Flanagan

http://www.w3.org/2001/XMLSchema#string

Brian Lewis

http://www.w3.org/2001/XMLSchema#string

Charles E Rose

http://www.w3.org/2001/XMLSchema#string

Christopher M Jones

http://www.w3.org/2001/XMLSchema#string

Elaine J Hallisey

http://www.w3.org/2001/XMLSchema#string

Eugene McCray

http://www.w3.org/2001/XMLSchema#string

Jessica L Kolling

http://www.w3.org/2001/XMLSchema#string

John T Brooks

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.

Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.

Supply of buprenorphine waivered physicians: the influence of state policies.

Patterns of prescription drug misuse among young injection drug users.

Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review.

The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction.

Drug poisoning deaths in the United States, 1980-2008.

Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

P304

323-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0000000000001098

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27763996

http://www.w3.org/2001/XMLSchema#string

P921

Ameeriga Ütisriigiq

P932

5479631

http://www.w3.org/2001/XMLSchema#string